Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N8FQ
|
||||
Former ID |
DAP000720
|
||||
Drug Name |
Reboxetine
|
||||
Synonyms |
Davedax; Edronax; Esreboxetine; Norebox; Prolift; Reboxitine; Solvex; Vestra; Reboxetine [INN]; Reboxetine mesylate; Davedax (TN); Edronax (TN); Norebox (TN); Prolift (TN); Reboxetine (INN); Solvex (TN); Vestra (TN); Esreboxetine (USAN/INN); (+-)-(2R*)-2-((alphaR*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine; (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; (2R)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; (S,S)-Reboxetine; (S,S)-reboxetine; 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate; 2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antidepressants
|
||||
Company |
Pfizer Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H23NO3
|
||||
InChI |
InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1
|
||||
InChIKey |
CBQGYUDMJHNJBX-OALUTQOASA-N
|
||||
CAS Number |
CAS 98769-81-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
8189987, 11114256, 14776713, 14801082, 24723456, 43122598, 46504845, 50065436, 50168465, 57315782, 85177295, 85753305, 96026020, 104046804, 104334847, 126650576, 126683279, 134338008, 135253190, 135785545, 137001349, 142214143, 160698609, 160963582, 163213628, 177749680, 178101510, 179338235, 198950509, 198973023, 223519262, 223686602, 226420981, 241124852, 241169861, 246640544
|
||||
SuperDrug ATC ID |
N06AX18
|
||||
SuperDrug CAS ID |
cas=098769814
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [535127] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References | |||||
Ref 468039 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4808). | ||||
Ref 536306 | Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.